A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

Five years on from the first news of COVID, recent reports of an obscure respiratory virus in China may understandably raise ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Banner Health encourages pregnant women to reduce their newborn’s risk of developing a severe illness through vaccination. Respiratory syncytial virus (RSV) season typically peaks in the winter and ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity—primarily organ transplant ...

NIH researchers identified MAD21-101, a novel antibody targeting a previously unexplored epitope on the malaria parasite.